Amgen Inc. (NASDAQ:AMGN) is included among the 10 Healthcare Stocks with Highest Dividends. UBS Sees Continued Upside in Amgen (AMGN), Lifts Target to $400 On April 13, UBS lifted its price recommendation on Amgen Inc. (NASDAQ:AMGN) to $400 from $390. It reiterated a Buy rating on the shares. The revision came as part of a broader Q1 preview across the pharmaceuticals and biotechnology group. On April 8, Truist also updated its view on the company. It boosted its price target to $325 from $319 and maint ...